
Sanofi commits ‘at least $20bn’ to US manufacturing through 2030
Sanofi has become the latest big pharma company to boost manufacturing in the US with a hefty investment as the biopharma industry safeguards itself against the continued threat of pharma tariffs from President Donald Trump. The French drugmaker said it …